Table 7.
In Vivo Model | EV-Source | EV Isolation Method | EV Route of Administration | EV Biological Effect | References |
---|---|---|---|---|---|
UUO mouse model Ligation of the left ureter and right ureter was not ligated |
m-BM-MSCs (30 µg EV/dose) Tail intravenous injection 1 day after the surgery |
UC | Two days of EPO incubation with m-BM-MSC and subsequent EPO-EVs isolation |
|
[70] |
UUO mouse model Ligation of the left ureter and right ureter was not ligated |
h-BM-MSCs (50 µg EV/dose) Intravenous injection twice a week for 4 weeks |
GETTM Exosome isolation kit | h-BM-MSC transfected with Let-7i-5p antagomir in presence of lipofectamine |
|
[71] |
UUO mouse model Ligation of the left ureter and right ureter was not ligated |
h-A-MSCs (1000 µg EV/dose) Tail intravenous injection |
UC | h-A-MSC lentiviral transfection with a vector plasmid system for GDNF gene |
|
[73] |
CKD mouse model Mice were fed with 0.25% adenine-containing diet |
h-A-MSCs (50-100 µg EV/dose) Tail intravenous injection for 2 weeks |
Exosome isolation kit | h-A-MSCs were treated with melatonin (1µM/mL) and subsequentially Exocue were isolated |
|
[75] |
STZ-DN rat model Intraperitoneal injection of STZ (65 mg/kg) |
h-USCs (100 μg EV/dose) Multiple intravenous injections once a week for 12 consecutive weeks |
Exo Quick-TC | Lentiviral transfection of h-USCs |
|
[76] |
Abbreviations: ultracentrifugation (UC), unilateral ureteral obstruction (UUO), streptozotocin diabetic nephropathy (STZ-DN), chronic kidney disease (CKD), bone marrow mesenchymal stromal cells (BM-MSCs), adipose mesenchymal stromal cells (A-MSCs), urinary stem cells, epithelial to mesenchymal transition (EMT).